Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer

European Journal of Pediatrics, Supplement

Volumn 158, Issue 3, 1999, Pages

  Mertens, R ^a,c   Brost, H ^a   Granzen, B ^a   Nowak Gottl U ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Antithrombin; Chemotherapy; Children; Veno occlusive disease

Indexed keywords

ANTITHROMBIN; ASPARAGINASE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; HEPARIN; LACTATE DEHYDROGENASE; PROTEIN C; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CASE REPORT; CHILDHOOD CANCER; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEPARINIZATION; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; INFANT; LIVER VENOOCCLUSIVE DISEASE; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0033373299     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014344     Document Type: Article

References (34)

1. Adachi N, Matsuda I (1992) Veno-occlusive disease of the liver after combined adjutant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY). J Pediatr Gastroenterol Nutr 14 (3):314-318
2. Bearman SI (1995) The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 85 (11):3005-3020
3. Bearman SI, Lee JL, Baron AE, McDonald GB (1997) Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 89 (5):1501-1506
4. Bearmann SI, Hinds MSN, Wolford JL, Petersen FB, Nuget DL, Slichter SJ, Shulman HM, Mc Donal GB(1990) A pilot study of continuous infusion heparin for prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant 5:407-411
5. Bisogno G, de Kraker J, Weirich A, Masiero L, Ludwig R, Tournade MF, Carli M (1997) Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol 29 (4):245-251
6. Culic S, de Kraker J, Kuljis D, Kuzmic I, Saraga M, Culic V, Balarin L, Primorac D (1998) Fatal hepatic veno-occlusive disease with fibrinolysis as the cause of death during preoperative chemotherapy for nephroblastoma. Med Pediatr Oncol 31 (3):175-176
7. Davidson A, Pritchard J (1998) Actinomycin D, hepatic toxicity and Wilms' tumor - a mystery explained? Europ Journ Cancer 34 (8):1145-1147
8. Dittmann WA, Majerus PW (1990) Structure and function of thrombmodulin: A natural anticoagulant. Blood 75:329-335
9. Eltumi M, Trivedi P, Hobbs JR (1993) Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen [see comments]. Lancet 342(8870):518-521
10. Faioni EM, Krachmalnicoff A, Bearman SI, Federici AB, Decarli A, Gianni AM, McDonald GB, Mannucci PM (1993) Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 81 (12):3458-3462
11. Gherlinzoni F, Vianelli N, Valdre L, Catani L, Tani M, Tura S (1999) Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease [letter] [In Process Citation]. Haematologica 84 (2):191-192
12. Goldberg SL, Shubert J, Rao AK, Redei I, Klumpp TR, Mangan KF (1996) Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile. Bone Marrow Transplant 18 (3):633-636
13. Hazar V, Kutluk T, Akyuz C, Varan A, Yaris N, Buyukpamukcu M (1998) Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney. Pediatr Hematol Oncol 15 (1):85-89
14. Higashigawa M, Watanabe M, Nishihara H, Tabata N, Azuma E, Ido M, Ito M, Sakurai M (1995) Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1. Leuk Res 19 (7):477-180
15. Jones RJ, Lee KSK, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Saaral R (1987) Venocclusive disease of liver following bone marrow transplantation. Transplantation 44:778-784
16. Kanwar VS, Albuquerque ML, Ribeiro RC, Kauffman WM, Furman WL (1995) Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature [see comments]. Med Pediatr Oncol 24 (5):334-340
17. Korte W (1997) Veno-occlusive disease of the liver after bone marrow transplantation: is hypercoagulability really part of the problem? Blood Coagul Fibrinolysis 8 (7):367-381
18. Kullendorff CM, Bekassy AN (1996) Hepatic veno-occlusive disease in Wilms' tumor. Eur J Pediatr Surg 6 (6):338-340
19. Lee JH, Lee KH, Kim S, Lee JS, Kim KW, Par CJ, Chi HS, Kim SH (1998) Relevance of protein C, antithrombin III, von Willebrand factor, and factor VIII for development of hepatic veno-occlusive disease in patients undergoing allogenic bone marrow transplantation : a prospective study. Bone Marrow Transplantation 22 (9):883-888
20. Lohse AW, Dienes HP, Wolfel T, Meyer zum Buschenfelde KH, Dippold W (1995) Veno-occlusive disease of the liver in Hodgkin's disease prior to and resolution following chemotherapy [letter]. J Hepatol 22(3):378
21. McDonald GB (1994) Veno-occlusive disease of the liver following marrow transplantation. Marrow Transpl Rev 3:49-56
22. Mc Donald GB, Hinds MS, Fisher LD (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118(4):255-267
23. Mc Donald GB, Sharma P, Matthews DE, Shulmann HW, Thomas ED (1984) Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence and predisposing factors. Heptology 4:16-24
24. Modzelewski JR, Daeschner C, Joshi VV, Mullick FG, Ishak KG (1997) Veno-occlusive disease of the liver induced by low-dose cyclophosphamide. Mod Pathol 7 (9):967-972
25. Park YD, Yasui M, Yoshimoto T (1993) Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation. Bone Marrow Transplant 19 (9):915-920
26. Patton DF, Harper JL, Wooldridge TN, Gordon BG, Coccia P, Haire WD (1996) Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate. Bone Marrow Transplant 17 (3):443-447
27. Richardson PG, Elias AD, Krishnan A (1998) Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 92 (3):737-744
28. Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Penovici M, Ledderose G, Hiller E (1999) The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation [In Process Citation]. Leuk Lymphoma 33 (1-2):25-32
29. Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W, Hiller E (1997) Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 89 (6):2184-2188
30. Salat C, Holler E, Wolf C (1997) Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation. Bone Marrow Transplant 19 (5):487-490
31. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB (1994) Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 19 (5):1171-1181
32. Shulman HM, Hinterberger W (1992) Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 10 (3):197-214
33. Trobs RB, Rothe K, Meier T (1996) [Hepatic veno-occlusive disease simulating acute abdomen in chemotherapy of Wilms' tumors]. Langenbecks Arch Chir Suppl Kongressbd 113:1112-1114
34. Yasutomo K, Himeno K (1993) Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen [letter; comment]. Lancet 342 (8878): 1062